Tuberculous pericarditis in an infant evolving during triple chemotherapy.

Abstract

UNLABELLED:

A 36-month-old girl was treated for pulmonary tuberculosis (Mycobacterium tuberculosis) with isoniazid, rifampin and pyrazinamide. Four weeks after starting chemotherapy, she developed high fever and clinical signs of acute pericardial tamponade. Pericardial effusion was shown by echocardiography and subsequently removed by pericardiocentesis. M. tuberculosis was demonstrated in the pericardial fluid by microscopy, polymerase chain reaction and specific culture. After pericardial drainage, the actual therapy was extended to include streptomycin and prednisone. Follow-up examinations demonstrated complete recovery without signs of constrictive pericarditis.

CONCLUSION:

infants treated for tuberculosis should be followed closely in order to monitor not only side-effects of antituberculous drugs but also to detect early extrapulmonary spread that may occur even with adequate chemotherapy. Rapid intervention and treatment adjustment in infants with tuberculous pericarditis may prevent pericardial constriction and may lead to full recovery.

• Authors: Jochen Meyburg, Klaus G Schmidt, Walter Nützenadel, Markus Bettendorf
• Journal: European journal of pediatrics (Eur J Pediatr) Vol. 161 Issue 3 Pg. 138-41 (Mar 2002) ISSN: 0340-6199 [Print] Germany
• PMID: 11998909 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antitubercular Agents
• Pyrazinamide
• Isoniazid
• Rifampin

Topics

• Antitubercular Agents (therapeutic use)
• Child, Preschool
• Drug Therapy, Combination
• Echocardiography
• Female
• Humans
• Isoniazid (therapeutic use)
• Pericardial Effusion (microbiology)
• Pericarditis, Tuberculous (diagnostic imaging, microbiology)
• Pyrazinamide (therapeutic use)
• Rifampin (therapeutic use)
• Tomography, X-Ray Computed
• Treatment Outcome
• Tuberculosis, Pulmonary (drug therapy, microbiology, pathology)